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ABSTRACT OF THESIS 
 
ACUTE ASCORBIC ACID ADMINISTRATION IMPROVES ENDOTHELIAL  
FUNCTION DURING RHYTHMIC BUT NOT SINGLE  
CONTRACTIONS IN AGING HUMANS 
 
Age-related increases in oxidative stress are known to impair endothelium 
dependent vasodilation in older healthy humans.  As a result, many researchers have 
speculated that endothelial dysfunction contributes to impaired muscle blood flow and 
vascular control during exercise.  Further, elevations in oxidative stress and subsequent 
endothelial dysfunction could possibly explain our recent observations of impaired 
contraction-induced rapid vasodilation in older adults.  Therefore, we directly tested the 
hypothesis that acute ascorbic acid administration would augment (1) rapid vasodilation 
in response to single muscle contractions as well as (2) the hyperemic response to 
sustained rhythmic contractions in older healthy humans, and that this would be due to 
improved endothelium-dependent vasodilation.   
In 14 young (22±1 yrs) and 14 healthy older men and women (65±2 yrs), we 
measured forearm blood flow (FBF; Doppler ultrasound) and calculated vascular 
conductance (FVC) responses to single, 1 second dynamic contractions at 10, 20, and 
40% maximum voluntary contraction (MVC) before and after intra-arterial 
administration of ascorbic acid (AA).  We also measured these variables during rhythmic 
handgrip exercise at 10% maximum voluntary contraction.  After 5 minutes of steady-
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state exercise with saline, ascorbic acid (AA) was infused via brachial artery catheter for 
10 minutes during continued exercise.   
For single contractions, prior to AA peak vasodilator responses to all contraction 
intensities were impaired ~35-50% in older adults (P<0.05), as were the immediate (1st 
cardiac cycle post contraction) vasodilator responses at 20 and 40% MVC (~50%; 
P<0.05).  In contrast to our hypothesis, AA did not influence contraction-induced rapid 
vasodilation in either group (all NS).  Regarding rhythmic handgrip exercise, FBF 
(~28%) and FVC (~31%) were lower in older vs young adults (P=0.06 and P<0.05) prior 
to AA.  In young adults, AA administration did not significantly influence FBF and FVC, 
whereas FBF and FVC increased 30±4% in older adults at end exercise (P<0.05).  AA 
did not influence vasodilator responses to sodium nitroprusside in either group, but 
significantly improved vasodilation to acetylcholine in older adults only (P<0.05).  
We conclude that endothelial dysfunction is not the primary mechanism 
underlying impaired contraction-induced rapid vasodilation with human aging; however 
acute AA administration increases muscle blood flow during dynamic exercise in older 
adults, which is likely due to an improvement in endothelium dependent vasodilation.  
 
Carrie Beth Simpson 
Health and Exercise Science Department 
Colorado State University 
Fort Collins, CO 80523 
Summer 2009
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REVIEW OF THE LITERATURE 
One of the hallmark changes associated with aging is a decline in endothelial 
vasodilator function, and this decline in function is believed to be due, in part, to an 
increase in oxidative stress (Taddei et al., 2000; Jablonski et al., 2007).  Oxidative stress 
may stem from increased free radical production, reduced capacity of metabolic pathways 
that have antioxidant functions, or a combination of these.  If the body’s antioxidant 
capabilities become overwhelmed or impaired, as seen with aging and numerous 
diseases, the vasculature becomes subject to damage by the continued presence of 
elevated oxidative stress.    
In addition to changes in the oxidation status of blood vessels, aging is also associated 
with changes in a person’s physiological response to exercise.  Exercise evokes an 
increase in blood flow to active skeletal muscle, but depending on the type of exercise 
stimulus employed (single or rhythmic contractions), different regulatory mechanisms are 
stimulated.  During continuous rhythmic muscle contractions, numerous elements 
contribute to exercise hyperemia, including mechanical deformation of the blood vessels, 
the sympathetic nervous system, release of local metabolic factors, and substances 
produced by the endothelium in response to increased levels of shear stress (Saltin et al., 
1998).  Following a brief, single muscle contraction, the hyperemic response occurs 
immediately (Corcondilas et al., 1964), is graded with contraction intensity (Tschakovsky 
et al., 2004), and is due to smooth muscle cell hyperpolarization (Hamann et al., 2004).  
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Interestingly, exercise hyperemia in attenuated in older adults during both sustained 
exercise (Lawrenson et al., 2003; Proctor & Parker, 2006)  and single muscle 
contractions (Carlson et al., 2008), and because age is also associated with endothelial 
dysfunction (Taddei et al., 2001) researchers have been prompted to hypothesize that 
declines in exercise hyperemia in older populations may be linked to age-related 
impairments in vascular function.  With these ideas in mind, the purpose of this review is 
to examine aging as it relates to vascular function and control during exercise as well as 
to establish a foundation for the present experiment. 
Aging and the Endothelium 
It is well known that the vascular endothelium is negatively affected by age 
(DeSouza et al., 2000; Taddei et al., 2000; Lawrenson et al., 2003; Poole et al., 2003; 
Eskurza et al., 2004), and endothelial dysfunction is a notorious precursor to numerous 
clinical conditions and cardiovascular diseases.  As the main interface between 
circulating blood and the vascular wall, the endothelium is an essential component of 
vascular control and blood flow regulation (Luscher & Vanhoutte, 1990) both at rest and 
during exercise.  If endothelial cells are damaged by hypertension, hypercholesterolemia, 
or other age-associated vascular conditions, the ability of these cells to properly function 
becomes compromised and the blood vessels’ capacity to maintain proper tone is 
impaired (Taddei et al., 1998; Taddei et al., 2001).    
More specifically, the endothelium has a primary role in maintaining vascular 
tone through its regulation of the production and release of nitric oxide (NO) (Taddei et 
al., 1998; Faraci & Didion, 2004).  If the endothelium becomes damaged or impaired in 
such a way that it cannot produce sufficient amounts of bioavailable NO, vascular tone is 
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not properly maintained or controlled.  Without proper regulation of vascular tone, blood 
vessels are unable to appropriately respond to stimuli requiring changes in blood pressure 
and blood flow, as is the case with exercise.  
In addition to nitric oxide, prostaglandin-mediated vasodilation helps to maintain 
blood flow during exercise (Clifford & Hellsten, 2004; Schrage et al., 2004).   
Vasodilating prostaglandins are produced by the endothelium as well as skeletal muscle 
(Clifford & Hellsten, 2004) and their production has been observed to decline with 
advancing age (Schrage et al., 2007).  Together, the reduction in both NO bioavailability 
and PG production with advancing age suggest that age-related declines in these 
substances may lead to impaired endothelium-dependent vasodilation in older 
populations.   For this reason, the homeostatic level of nitric oxide and prostaglandins is 
an important element to take into account when addressing endothelial function and 
blood flow regulation in both young and older individuals during exercising conditions.   
Additionally, the contribution of oxidative stress to age-related declines in 
endothelium-dependent vasodilation is noteworthy due to the consequential decrease in 
vasoactive substances that leads to impairments in blood flow.  Elevations in oxidative 
stress not only damage blood vessel walls, but the free radicals responsible for causing 
such stress and damage also react readily with nitric oxide.  In fact, the superoxide anion, 
which is commonly present at increased concentrations with age, reacts with NO to form 
peroxynitrate (ONOO-) at a rate approximately three times faster than it does with the 
enzyme superoxide dismutase (Faraci & Didion, 2004; Jackson et al., 2007).  This 
reaction not only perpetuates the continued production of free radicals, but it also 
consumes available nitric oxide (Gryglewski et al., 1986), thereby reducing the net 
4 
 
bioavailability of NO and leading to impaired vasodilation in older individuals.  Taken 
together, the combined effect of reduced production and/or increased breakdown of 
endothelial-derived vasodilatory substances can lead to impaired endothelium-dependent 
dilation, and the manner in which these processes may affect blood flow regulation 
during exercise can be considerable, especially in older individuals. 
Aging and Oxidative Stress 
Regarding age in particular, impairment of the endothelium is evidenced by 
progressively weakened responses to endothelium-dependent vasodilation in older 
individuals (Taddei et al., 1995; DeSouza et al., 2000; Taddei et al., 2000; Taddei et al., 
2001).  Advancing age has been associated with an increase in oxidative stress and 
subsequent endothelial dysfunction  (Shigenaga et al., 1994; Taddei et al., 2001), and one 
of the primary putative contributors to this oxidative stress is increased free radical 
production (Jablonski et al., 2007; Rizvi & Maurya, 2007), possibly combined with 
impaired functioning of antioxidant pathways (Rizvi & Maurya, 2007). 
Free radicals are a form of reactive oxygen species (ROS) that have one unpaired 
electron and can react in vivo to cause damage to DNA, proteins, lipids, the vasculature, 
and more (Shigenaga et al., 1994; Jackson et al., 2007).  Superoxide (O2-) is the initial 
product of a one-electron reduction of oxygen, and it is the precursor for most ROS, as 
well as an intermediate in the process of oxidative chain reactions that go on to generate 
more free radicals.  As alluded to previously, increased levels of superoxide and other 
ROS have been shown to decrease NO bioavailability, contributing to enhanced vascular 
resistance (Ungvari et al., 2003; Plantinga et al., 2007) and the possibility for cellular 
damage.  As relatively more free radicals are generated than broken down by antioxidant 
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defense mechanisms, the process of ‘oxidative stress’ begins, rendering the vasculature 
susceptible to harmful effects such as plaque formation, increased stiffness, and altered 
responsiveness to vasoactive substances (Luscher et al., 1993b; Wu & Thiagarajan, 1996; 
Shimokawa, 1999; Rizvi & Maurya, 2007), all of which increase a person’s risk of 
developing vascular disease. 
Further, because free radicals are believed to be one of the main factors leading to 
a decline in NO bioavailability, they are also identified as having a role in reducing 
endothelium-dependent vasodilation (Shigenaga et al., 1994; Taddei et al., 2001; Rizvi & 
Maurya, 2007). To illustrate this concept, researchers commonly evaluate endothelial 
function of the vasculature using acetylcholine and sodium nitroprusside to assess 
endothelium-dependent and endothelium-independent vasodilation, respectively.  Most 
often, vasodilation in response to acetylcholine has been observed to decline with age 
(DeSouza et al., 2000; Taddei et al., 2000; Taddei et al., 2001), while the response 
sodium nitroprusside more commonly does not differ among age groups (DeSouza et al., 
2000; Taddei et al., 2001).  Because acetylcholine acts directly on the endothelium to 
cause dilation, whereas sodium nitroprusside acts via the surrounding smooth muscle, the 
impaired vasodilatory response traditionally points to endothelium-dependent dilation as 
the element that is impaired with age.  It is important to note, however, that vasodilation 
induced by sodium nitroprusside has also been shown to decline with age (Taddei et al., 
2000; Newcomer et al., 2005; Parker et al., 2006), which means that changes in vascular 
smooth muscle cells cannot be completely ruled out as having no influence on vascular 
control with age. 
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Due to the increased presence of free radicals in the vasculature of older 
individuals, antioxidants are commonly used as a means of evaluating endothelial 
function and blood flow regulation with less influence from high levels of oxidative 
stress.  Ascorbic acid is a common antioxidant used in the laboratory, and at 
supraphysiologic levels it has the ability to scavenge free radicals within the vasculature.  
By decreasing the concentration of free radicals, ascorbic acid restores the bioavailability 
of nitric oxide, allowing it to properly function as a vasodilator and augment regional 
blood flow (Eskurza et al., 2004; Jablonski et al., 2007).  In older subjects, ascorbic acid 
supplementation has been shown to decrease the markers of oxidative stress, and improve 
both endothelium-dependent and flow mediated dilation in the brachial artery (Eskurza et 
al., 2004).  It has also been used to successfully restore resting blood flow to the femoral 
artery in older males, bringing resting blood flow values up to levels observed in young 
males (Jablonski et al., 2007).   
Considering the negative effects of age and oxidative stress on the vasculature, it 
is possible that endothelial dysfunction, which has thus far been observed mainly in 
response to pharmacological stimuli, may also have an impact on a person’s ability to 
regulate blood flow during exercise.  In fact, while age-related reductions nitric oxide-
mediated vasodilation have been linked with impaired endothelium-dependent 
vasodilation (Taddei et al., 1995; Taddei et al., 2000), there is no direct evidence to 
indicate whether this impairment extends to the vessel’s ability to control blood flow 
during a hyperemic stimulus like exercise.  Therefore, additional research is necessary to 
determine if there is in fact a link between age-associated endothelial dysfunction and 
blood flow regulation during exercise. 
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Aging and Exercise Capacity 
 In addition to changes in the oxidation status of blood vessels, aging is also 
associated with changes in a person’s physiological response to exercise and a 
corresponding decline in exercise capacity (Holloszy & Kohrt, 1995).  Exercise capacity 
is multidimensional, relating to one’s aerobic capacity (VO2 max), cardiopulmonary 
endurance, muscular strength, and physical ability.  As such, it is a useful tool for 
evaluating the overall health of an individual and is related to one’s risk for future disease 
development (Myers et al., 2002).  Peak exercise capacity has been determined to be a 
stronger predictor of increased risk of death than clinical symptoms in both healthy 
individuals and those with cardiovascular disease (Myers et al., 2002).  Additionally, 
reductions in exercise capacity frequently lead to declines in functional capacity, loss of 
independence, and an overall reduction in quality of life for older individuals (Holloszy 
& Kohrt, 1995).  
Given the well known decline in endothelial function with age, it is plausible to 
speculate that this impairment of the vasculature relates to age-associated declines in 
exercise capacity as well, since the endothelium is a primary regulator of blood flow and 
vascular conductance and exercise requires an increase in both.  However, despite the 
reasoning of this explanation, it remains unclear whether these changes occur 
independently or jointly.  In fact, there is no direct evidence to indicate that exercise 
capacity and endothelial function develop independent of one another; nor is there clear 
evidence directly linking endothelial dysfunction to reductions in exercise capacity.  In 
this context, further investigations are required to determine if any link exists between 
these two elements and to what degree they may or may not influence one another. 
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Aging and Exercising Blood Flow and Vascular Control 
 As mentioned previously, age-related declines in endothelial function (DeSouza et 
al., 2000; Taddei et al., 2000; Lawrenson et al., 2003; Poole et al., 2003) have important 
implications for blood flow regulation to skeletal muscle both at rest and during exercise.   
Specifically in reference to exercise, older adults display attenuated blood flow responses 
during both small (Lawrenson et al., 2003) and large (Poole et al., 2003; Proctor et al., 
2003) muscle mass exercise.  Given that blood flow responses to each type of exercise 
are lower with age, it appears as though age-associated declines occur on many levels and 
are not necessarily limited to the size of the muscle.   
Additionally, during exercising conditions adequate blood flow is required in 
order to sustain continuous contractions (Clifford & Hellsten, 2004; Proctor & Parker, 
2006).  If blood flow is limited during exercise, the active muscle is faced with oxygen 
and nutrient deprivations that in turn lead to fatigue, subsequent cessation of exercise, 
and eventual declines in exercise capacity. Because exercise capacity generally declines 
with age (Holloszy & Kohrt, 1995) along with endothelial vascular function (DeSouza et 
al., 2000; Taddei et al., 2000; Lawrenson et al., 2003; Poole et al., 2003; Eskurza et al., 
2004), researchers have been prompted to speculate that age-related declines in muscle 
blood flow and aerobic capacity potentially result from impairments in endothelial 
control of vascular tone during exercise.  Suitably, elevated oxidative stress is a common 
explanation for the attenuated blood flow responses seen in older subjects (relative to 
young adults) during exercise.  Recalling the previous discussion, it has been 
demonstrated that high levels of oxidative stress impair endothelium-dependent dilation 
by interfering with the bioavailability of nitric oxide (Ungvari et al., 2003; Plantinga et 
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al., 2007), thereby reducing the blood vessel’s ability to relax and subsequently allow for 
increased blood flow to active skeletal muscle (Shigenaga et al., 1994; Taddei et al., 
2001; Rizvi & Maurya, 2007).  By interfering with the production of nitric oxide, free 
radicals essentially lessen the vasodilator’s influence on the vasculature and nullify its 
vasodilatory effects, therefore contributing to impaired blood flow responses during 
exercise. 
Of further note on this topic is the fact that there appears to be some form of 
redundancy acting on the vessels to maintain exercising blood flow in individuals who 
are at risk for endothelial dysfunction, such as older adults.  In particular, when both 
nitric oxide and vasodilating prostaglandins (PGs), are inhibited during exercise (Boushel 
et al., 2002; Schrage et al., 2004), there is a resulting decrease in exercising blood flow to 
the active muscle.  A similar reduction in exercising blood flow is seen with single 
inhibition of nitric oxide; however, the same response is not observed when PGs alone 
are inhibited.  Instead, there is almost no effect on exercising muscle blood flow with 
single blockade of PGs (Schrage et al., 2004), which implies the existence of some type 
of complementary mechanism acting to restore or maintain blood flow when PG 
formation is inhibited during exercise.  Such redundancy may have important 
implications for populations displaying endothelial dysfunction, such as older 
individuals, who may not have the ability to regulate the production and release of these 
substances as well as young healthy individuals during an exercise stimulus. 
Despite the stimulus for vasodilation and the interaction of these pathways during 
exercise, local vasodilation is simultaneously balanced by a certain degree of 
vasoconstriction in active muscles with the purpose of maintaining systemic blood 
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pressure (Buckwalter et al., 1997; O'Leary et al., 1997; Proctor & Parker, 2006).  As a 
means of shunting blood to active skeletal muscle, exercise brings about vasoconstriction 
in inactive tissue along with local vasodilation in active regions of the body (Proctor & 
Parker, 2006).  However, during large muscle mass exercise, when substantial 
vasodilation is necessary to meet the metabolic demand of the tissue, the vasodilatory 
stimulus in the active muscle must be simultaneously limited by some level of 
vasoconstriction in order to prevent steep declines in systemic blood pressure (Proctor & 
Parker, 2006).  Interestingly, the level of tonic sympathetic nerve activity present in older 
individuals is commonly elevated (Sundlof & Wallin, 1978; Ng et al., 1993), leading to 
enhanced vasoconstriction in this population.  This elevated sympathetic nerve activity 
has been associated with decreased exercising blood flow and, in fact, during both 
submaximal and maximal leg exercise, attenuated blood flow has been observed in older 
adults relative to their younger counterparts (Proctor & Parker, 2006).  Such reductions in 
blood flow are coupled with decreased vascular conductance, which may potentially 
result from reduced vasodilator production (as a result of endothelial impairment), 
augmented sympathetic constriction, or a combination of both  that interact to limit 
exercising blood flow.   
Nonetheless, there appears to be significant alterations in the regulation of the 
hyperemic response to exercise in older compared to young adults.  While there are 
numerous elements interacting to maintain the appropriate level of blood flow and 
vascular tone during exercise, including mechanical deformation of the blood vessels, the 
sympathetic nervous system, release of local metabolic factors (K+, adenosine, ATP, and 
NO), and substances produced by the endothelium in response to increased shear stress 
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(Saltin et al., 1998; Clifford & Hellsten, 2004; Proctor & Parker, 2006), it seems that 
these pathways and the ensuing responses may be linked at some level to the endothelium 
and how well it is able to respond to the stress of exercise.  Also, as a consequence of 
healthy human aging, the contribution of both nitric oxide and vasodilating 
prostaglandins to exercise hyperemia is significantly reduced, indicating that these 
pathways are not augmenting exercise hyperemia to the same degree as they are in 
younger individuals (Schrage et al., 2004; Schrage et al., 2007).  Specifically, when 
compared to young adults, nitric oxide-mediated vasodilation is reduced  by 
approximately 40% and prostaglandin-mediated vasodilation appears to be completely 
abolished in older subjects  (Schrage et al., 2004).  Taken together, it is apparent that 
blood flow regulation during exercise is negatively influenced by age, and altered 
vasodilatory pathways may contribute to both reductions in exercise hyperemia as well as 
increased sympathetic constriction leading to reduced blood flow during exercise 
(Schrage et al., 2004).   
Aging and Contraction-Induced Rapid Vasodilation 
In response to single, brief muscle contractions, the hyperemic response in healthy 
humans peaks within 4-6 cardiac cycles post-contraction and is graded with contraction 
intensity (Tschakovsky et al., 2004; Carlson et al., 2008).  Additionally, by clamping 
smooth muscle cell membrane potential within the skeletal muscle of dogs, Hamman and 
colleagues successfully demonstrated that the hyperemic response to a contraction was 
virtually abolished upon inhibition of hyperpolarization (Hamann et al., 2004).    These 
results led to the conclusion that rapid vasodilation results from smooth muscle cell 
hyperpolarization rather than activation of the skeletal muscle pump, and this rapid 
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vasodilation is now recognized as obligatory in the process of increased muscle blood 
flow upon contraction (Hamann et al., 2004).  Along with hyperpolarization, the 
endothelium has also been determined to be an important component to vasodilation.  As 
shown by  Clifford and colleagues, removal of the vascular endothelium in isolated blood 
vessels leads to a significant reduction (~30%) in the degree of dilation observed in 
response to a mechanical stimulus (Clifford et al., 2006).  While dilation was not 
completely abolished upon removal of the endothelium, the attenuated response to the 
stimulus does provide strong evidence to support the role of the endothelium in the 
process of vasodilation.  
  Commonly, when blood flow regulation and vasodilatory responses have been 
assessed during exercise, they have been paired with rhythmic contractions that are 
maintained for a period of time.  More recently, there has been a shift towards 
understanding the regulation of blood flow in response to a single muscle contraction 
because single contractions afford researchers the ability to examine vascular tone 
independent of the effects of subsequent contractions (Hamann et al., 2004; Tschakovsky 
et al., 2004; Kirby et al., 2007) and sympathetic nervous system influences (Corcondilas 
et al., 1964; Buckwalter & Clifford, 1999).  Small muscle mass exercise in particular is 
useful when evaluating this response because it does not elicit changes in mean arterial 
pressure or heart rate (Tschakovsky et al., 2004; Kirby et al., 2007; Carlson et al., 2008), 
which may influence the interpretation of the cause of hyperemia. 
Applying these concepts to human aging, recent data from our laboratory indicate 
that contraction-induced rapid vasodilation is significantly impaired in older compared 
with young healthy adults (Carlson et al., 2008), and to the best of our knowledge, this 
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issue has not been previously investigated in relation to the potential influences of 
oxidative stress and endothelial dysfunction.  However, because the endothelium has an 
essential role in vasodilation (Clifford & Hellsten, 2004), and it is well established that 
endothelial function is impaired with age, it is possible that the hyperemic response to 
single contraction may be impaired in older adults due to age-associated elevations in 
oxidative stress.  In this context, further investigations are necessary to determine if the 
effect of age and any associated declines in endothelial function influence contraction-
induced hyperemia in the same manner as steady state exercise. 
 
Statement of the Problem 
Whether impaired endothelial function is mechanistically-linked to the observed 
blunted contraction-induced rapid vasodilation in older humans is unknown.  Also, there 
is no definitive evidence directly linking impaired endothelial function to attenuated 
vascular control during dynamic exercise in older populations, and it is not known 
whether improvements in endothelial function lead to enhanced exercise hyperemia in 
older adults.   
 
Hypothesis 
Therefore, we sought to test the hypothesis that acute ascorbic acid administration 
would augment (1) rapid vasodilation in response to single muscle contractions as well as 
(2) the hyperemic response to sustained contractions in older healthy humans, and that 
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Age-related increases in oxidative stress impair endothelium-dependent vasodilatation in 
humans, leading to the speculation that endothelial dysfunction contributes to impaired 
muscle blood flow and vascular control during exercise in older adults.  We directly 
tested this hypothesis in 14 young (22±1 yrs) and 14 healthy older men and women (65±2 
yrs).  We measured forearm blood flow (FBF; Doppler ultrasound) and calculated 
vascular conductance (FVC) responses to single muscle contractions at 10, 20, and 40% 
maximum voluntary contraction (MVC) before and during ascorbic acid (AA) infusion, 
and we also determined the effects of AA on muscle blood flow during mild (10% MVC) 
continuous rhythmic handgrip exercise.  For single contractions, the peak rapid 
hyperaemic responses to all contraction intensities were impaired ~45% in the older 
adults (all P < 0.05), and AA infusion did not impact the responses in either age group.  
For the rhythmic exercise trial, FBF (~28%) and FVC (~31%) were lower (P = 0.06 and 
0.05) in older versus young adults after 5 minutes of steady-state exercise with saline.  
Subsequently, AA was infused via brachial artery catheter for 10 minutes during 
continued exercise.  AA administration did not significantly influence FBF or FVC in 
young adults (1-3%; P = 0.24-0.59), whereas FBF increased 34±7% in older adults at end 
exercise, and this was due to an increase in FVC (32±7%; both P < 0.05).  This increase 
in FBF and FVC during exercise in older adults was associated with improvements in 
vasodilator responses to acetylcholine (ACH; endothelium-dependent) but not sodium 
nitroprusside (SNP; endothelium-independent).  AA had no effect on ACH or SNP 
responses in the young.  We conclude that acute AA administration does not impact the 
observed age-related impairment in the rapid hyperaemic response to brief muscle 
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contractions in humans, however it does significantly increase muscle blood flow during 
continuous dynamic exercise in older adults, and this is likely due (in part) to an 
























Blood flow and oxygen delivery increase to contracting muscle, a complex 
response involving mechanical factors, the sympathetic nervous system, as well as local 
metabolic and endothelium-derived substances that influence vascular tone (Saltin et al., 
1998).  With respect to the latter, a variety of local endothelium-dependent vasodilators 
are recognized to increase during exercise and partially control blood flow and vascular 
tone in contracting human skeletal muscle (Clifford & Hellsten, 2004; Saltin, 2007).  For 
example, local inhibition of nitric oxide and vasodilating prostaglandins during rhythmic 
handgrip exercise independently reduces forearm hyperaemia in young healthy humans 
(Schrage et al., 2004), and combined inhibition of these substances has been documented 
to reduce muscle blood flow during knee extensor exercise (Boushel et al., 2002; 
Mortensen et al., 2007).  Additionally, recent work by Hillig and colleagues 
demonstrated redundancy between nitric oxide and the cytochrome P450 pathway, 
leading to the speculation that an endothelium-derived hyperpolarizing factor increases 
during exercise and is also involved in local vascular control (Hillig et al., 2003).  
Together, these observations indicate a significant role of the endothelium in regulating 
exercise hyperaemia in healthy humans.     
Human ageing is associated with a progressive decline in endothelial function that 
predisposes older adults to increased risk for thrombosis, atherosclerotic vascular disease, 
as well as ischemic heart and cerebrovascular disease (Luscher et al., 1993b; Wu & 
Thiagarajan, 1996; Shimokawa, 1999).  Ageing is also associated with reductions in 
exercise capacity (Holloszy & Kohrt, 1995), and this may be due in part to impaired 
blood flow and oxygen delivery to contracting muscles (Lawrenson et al., 2003; Poole et 
18 
 
al., 2003; Proctor et al., 2003).  Collectively, these findings have lead to the hypothesis 
that impaired endothelial vasodilator function contributes to exercise intolerance with age 
and other disease states involving endothelial dysfunction via impaired vascular control 
during exercise (Drexler & Hornig, 1996; Proctor & Parker, 2006).  Consonant with this 
concept, recent work by Schrage and colleagues indicates that the normal contributions of 
endothelium-derived nitric oxide and vasodilating prostaglandins to exercise hyperaemia 
are significantly reduced with age in older healthy humans (Schrage et al., 2007).  
Although the mechanisms underlying these changes are unclear, age-related increases in 
oxidative stress are suggested to impair endothelium-dependent vasodilatation in humans, 
and accumulating data indicates that acute antioxidant administration (e.g., ascorbic acid) 
can reverse endothelial dysfunction as evidenced by the restoration of acetylcholine- and 
flow-mediated vasodilatation in older adults (Taddei et al., 2001; Eskurza et al., 2004).  
Despite these observations, it is presently unknown whether acutely improving 
endothelial function augments muscle blood flow via local vasodilatation during dynamic 
exercise in older humans.   
 To date, the majority of studies designed to understand muscle blood flow and 
vascular control in exercising young and older adults have been performed during steady-
state exercise.  However, in recent years, particular attention has been given to the rapid 
hyperaemic response following a single muscle contraction, as this allows for the 
determination of contraction-induced vasodilatation without the impeding effects of 
subsequent contractions on vascular tone (Hamann et al., 2004; Tschakovsky et al., 2004; 
Kirby et al., 2007).  Additionally, the mechanisms influencing vascular tone at exercise 
onset appear to differ from those involved in the control during steady-state exercise 
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(Clifford & Hellsten, 2004).  Upon the release of a single contraction, the typical rapid 
hyperaemic response peaks within 3-6 cardiac cycles and the magnitude is graded with 
contraction intensity (Tschakovsky et al., 2004; Kirby et al., 2007).   Importantly, this 
response is independent of sympathetic neural influences (Corcondilas et al., 1964; 
Buckwalter & Clifford, 1999), and during small muscle mass exercise (e.g., isolated 
handgrip), can also occur without significant changes in heart rate and arterial pressure 
(Tschakovsky et al., 2004; Kirby et al., 2007; Carlson et al., 2008).  Thus, under specific 
experimental conditions, this rapid hyperaemic response reflects a local vasodilator 
response within the vascular bed of the contracting muscle.  With respect to ageing, we 
recently documented that skeletal muscle contraction-induced rapid vasodilation is 
significantly impaired in the forearm vasculature of older healthy adults (Carlson et al., 
2008).  It is currently unknown whether impaired endothelial vasodilator function is 
mechanistically-linked with this blunted rapid vasodilatory pattern following a single 
brief muscle contraction.  Further, whether improving endothelium-dependent 
vasodilatation restores the blunted rapid hyperaemia in older adults has not been 
investigated.   
Accordingly, the purpose of the present study was to directly test the hypothesis 
that acute improvements in endothelium-dependent vasodilator function via brachial 
artery infusion of ascorbic acid augments blood flow to contracting muscle of older 
adults via local vasodilatation.  To do so, we determined the effects of ascorbic acid in 
young and older adults on (1) forearm haemodynamic responses to single, brief muscle 
contractions, (2) forearm haemodynamics during dynamic (continuous) contractions of 
the forearm muscles, and (3) the vasodilator responses to intra-arterial infusions of 
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endothelium-dependent (acetylcholine) and endothelium-independent (sodium 




With Institutional Review Board approval and after written informed consent, a 
total of 14 young and 14 older healthy adult men and women participated in the present 
study.  All subjects were normotensive and free from overt cardiovascular disease as 
assessed from casual blood pressure measurements and a medical history.  Older subjects 
were further evaluated for clinical evidence of cardiopulmonary disease with a physical 
examination and resting and maximal exercise electrocardiograms.  All subjects were 
sedentary to moderately active, non-smokers, not taking any medications including 
antioxidants, and studies were performed after a minimum of a 4-hour fast.  Subjects 
provided written, informed consent after all potential risks and procedures were 
explained.  This study was approved by the Human Research Committee of Colorado 
State University and was performed according to the Declaration of Helsinki.   
 
Arterial Catheterization 
A 20-gauge, 7.6-cm catheter was placed in the brachial artery of the non-
dominant arm under aseptic conditions after local anesthesia (2% lidocaine) for local 
administration of study drugs.  The catheter was connected to a 3-port connector as well 
as a pressure transducer for mean arterial pressure (MAP) measurement and continuously 
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flushed at 3 ml h-1 with heparinized saline (Dinenno et al., 2003; Dinenno & Joyner, 
2004; Kirby et al., 2008).  The two side ports were used for infusions of vasoactive drugs. 
 
Blood Samples 
 Measures of total cholesterol, low- and high-density lipoproteins (LDL and HDL), 
and triglycerides were performed via conventional methods by the clinical laboratory of 
the Poudre Valley Hospital (Fort Collins, CO).  Oxidized-LDL was measured via 
standard Elisa assay (Mercodia, Inc., Uppsala, Sweden) as a marker of circulating 
oxidative stress via the General Clinical Research Center of the Milton S. Hershey 
Medical Center (Hershey, PA). 
 
Body Composition and Forearm Volume 
Body composition was determined by dual-energy X-ray absorptiometry (DEXA; 
DPX-IQ, Lunar Radiation). Total forearm volume and fat-free mass (FFM) were 
calculated from regional analysis of the experimental forearm (from the proximal to distal 
radioulnar joint) from whole-body DEXA scans with Lunar software version 4.7e for 
normalization of individual drug doses (Dinenno et al., 2002; Carlson et al., 2008).  Body 
mass index was calculated as bodyweight (kg) divided by height (meters) squared. 
 
Forearm Blood Flow and Vascular Conductance 
A 4 MHz pulsed Doppler probe (Model 500V, Multigon Industries, Mt. Vernon, 
NY, USA) was used to measure brachial artery mean blood velocity (MBV) with the 
probe securely fixed to the skin over the brachial artery proximal to the catheter insertion 
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site as previously described by our laboratory (Dinenno & Joyner, 2003; Kirby et al., 
2007; Carlson et al., 2008).  The probe insonation angle relative to the skin was 45 
degrees.  A linear 12 MHz echo Doppler ultrasound probe (GE Vingmed Ultrasound 
Vivid7, Horten, Norway) was placed in a holder securely fixed to the skin immediately 
proximal to the velocity probe to measure brachial artery diameter.  For the single 
contraction trials, brachial artery diameter was measured in triplicate prior to any 
contractions, as we and others have shown that brachial diameter does not change in 
response to this stimulus (Tschakovsky et al., 2004; Carlson et al., 2008).  For the 
rhythmic handgrip exercise trials, brachial diameter was measured in triplicate at rest and 
at each minute of exercise.  For the pharmacological tests, brachial diameter was 
measured in triplicate at rest and after 5 minutes of drug infusion (see below for details).  
Forearm blood flow was calculated as: 
FBF = MBV (cm s-1) * π (brachial artery diameter/2)2 * 60, where the FBF is in 
ml min-1, the MBV is in cm s-1, the brachial diameter is in cm, and 60 is used to convert 
from ml s-1 to ml min-1.  Forearm vascular conductance (FVC) was calculated as 
(FBF/MAP) * 100, and expressed as ml min -1 100 mmHg-1.   
 
Single Dynamic Forearm Contractions 
Maximum voluntary contraction (MVC) was determined for the experimental arm 
as the average of three maximal squeezes of a handgrip dynamometer (Stoelting, 
Chicago, IL) that were within  3% of each other.  Brief, dynamic forearm contractions 
were performed at 10, 20, and 40% of the subject’s MVC using a handgrip pulley system 
attached to weights corresponding to each workload.  The weight was lifted 4-5 cm over 
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the pulley for a single, 1-second dynamic contraction as previously described (Carlson et 
al., 2008).  These mild-to-moderate contraction intensities were chosen to limit the 
contribution of systemic haemodynamics to forearm vasodilator responses and to 
eliminate reflex increases in sympathetic nervous system activity, and thus isolate the 
local effects of muscle contraction on vascular tone (Carlson et al., 2008).  Two minutes 
of relaxation were given between each contraction to allow continuous measures of 
forearm haemodynamics post-contraction, as well as ample time for haemodynamics to 
return to baseline values (Tschakovsky et al., 2004; Kirby et al., 2007; Carlson et al., 
2008).  Workload intensity was randomized and counterbalanced across subjects to 
eliminate any order effect and trials were performed in triplicate to calculate an average 
response for each subject.   
 
Rhythmic Handgrip Exercise 
Using the same pulley system, subjects performed rhythmic, dynamic handgrip 
exercise at 10% MVC with a duty cycle of 1s contraction - 2s relaxation (20 contractions 
per minute) using audio and visual signals to ensure the correct timing (Dinenno & 
Joyner, 2003; Kirby et al., 2008).  Similar to the rationale provide above, this mild 
intensity rhythmic handgrip exercise was chosen to (a) limit the contribution of systemic 
haemodynamics to forearm hyperaemic responses and (b) eliminate reflex activation of 
the sympathetic nervous system (Seals & Victor, 1991; Carlson et al., 2008).  Further, 
mild contractions can be performed for a significant amount of time without evoking 
progressive increases in heart rate and arterial pressure (Schrage et al., 2004; Schrage et 
al., 2007).  Thus, our experimental model aims to isolate the local effects of muscle 
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contractions on forearm hyperaemia without engaging potentially confounding systemic 
influences on vascular tone. 
 
Vasoactive Drug Administration 
Endothelium-dependent vasodilatation was determined by intra-arterial infusion 
of acetylcholine (ACH; Miochol-E, Novartis Inc.) at 16 µg 100ml-1 forearm volume min-1  
for 5 minutes and endothelium-independent vasodilatation was assessed via intra-arterial 
infusion of sodium nitroprusside (SNP; Nitropress, Hospira Inc.) at 4 µg 100ml forearm 
volume-1  min-1  for 5 minutes (DeSouza et al., 2000; DeSouza et al., 2002).  As a method 
of acutely improving endothelium-dependent vasodilatation (Taddei et al., 2000; Taddei 
et al., 2001), the potent antioxidant ascorbic acid (Vitamin C, American Regent Inc.) was 
infused at 8 mg 100 ml forearm volume-1 min-1  for 10 minutes during handgrip exercise 
as a loading dose (see Experimental Protocol below), and at 40% of this loading dose for 
maintenance infusion throughout the remainder of the experiment.   
 
Experimental Protocol 
Subjects were studied in the supine position with the experimental arm extended 
90º laterally at heart level.  The experimental timeline is depicted in Figure 1.  Two 
minutes of resting data were acquired prior to all experimental trials.  To establish 
endothelium-dependent and -independent vasodilator responsiveness, ACH and SNP 
(respectively) were individually infused via brachial artery catheter for 5 minutes.  The 
order of ACH and SNP was counterbalanced across subjects and 15 minutes of rest was 
allowed following each drug infusion.  Next, subjects performed single brief forearm 
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contractions at 10, 20, and 40% MVC for 1-second with 2 minutes of rest in between 
contractions.  After 10 minutes of rest, rhythmic handgrip exercise was performed at 10% 
MVC with saline for 5 minutes to achieve steady-state haemodynamics, and ascorbic acid 
was then infused during continued exercise for 10 more minutes equaling a total time of 
15 minutes of handgrip exercise (Trial 1).  The dose of ascorbic acid was reduced to 40% 
of the original dose for the remainder of the experiment.  Following 15 minutes of rest, 
ACH and SNP infusions were repeated during maintenance ascorbic acid administration 
to determine the influence of ascorbic acid on endothelium-dependent and -independent 
vasodilatation.  Single forearm contractions were again performed to determine the 
impact of ascorbic acid on contraction-induced rapid vasodilatation.  Lastly, a second 
trial (Trial 2; n = 13 for young, n = 14 for older) of rhythmic handgrip exercise was 
performed for 5 minutes to determine forearm haemodynamics during the transition from 
rest to steady-state exercise with ascorbic acid already present and to confirm that any 
changes in forearm haemodynamics during Trial 1 were not simply due to a ‘time effect’ 
of continued exercise.  
  
Data Acquisition and Analysis 
Data was collected and stored on computer at 250 Hz and analyzed off-line with 
signal-processing software (WinDaq, DATAQ Instruments, Akron, OH, USA).  Mean 
arterial pressure (MAP) was determined from the arterial pressure waveform.  Baseline 
FBF, HR, and MAP represent an average of the last minute of the resting time period 
prior to all exercise trials and pharmacological vasodilatory tests.  The data presented for 
the ACH and SNP trials represent the final 30-seconds of drug infusion.  For the single 
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contraction trials, the post-contraction data represent the first unimpeded cardiac cycle 
immediately after release of the contraction, and this beat-by-beat analysis was performed 
for a total of 30 cardiac cycles (Tschakovsky et al., 2004; Kirby et al., 2007; Carlson et 
al., 2008).  For the rhythmic exercise trials, the minute-by-minute hyperaemic (FBF) and 
vasodilatory values (FVC) represent the last 30 seconds of that minute at rest and during 
exercise.  The % change in FBF during drug infusions and exercise was calculated as:  
((FBF drug or exercise - FBF baseline)/(FBF baseline)) x 100.   





All values are reported as means ± S.E.M.  Comparison of subject characteristics 
and the haemodynamic values at specific time points between groups for the ACH, SNP, 
and exercise conditions were made with unpaired t-tests, and the within group values for 
each hyperaemic condition with paired t-tests.  Specific hypothesis testing within exercise 
trials was performed to assess mean group differences between young and older adults 
using two-way repeated measures analysis of variance.  Post-hoc analysis was performed 
using the Tukey’s test when significance was observed.  Significance was set at P < 0.05. 
 
Results 
Subject Characteristics  
The mean age difference between the young and older adults was 43 yrs.  There 
were no significant age-group differences in BMI, whole-body FFM, forearm volume, 
forearm FFM, MVC, or HDL-cholesterol.  Older individuals had a greater body fat 
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percentage and total and LDL-cholesterol (P < 0.05; Table 1), although these values were 
within normal levels.  Baseline haemodynamics for all trials were not different between 
young and older adults.   
 
Effect of Ascorbic Acid on Forearm Haemodynamic Responses to Single Muscle 
Contractions 
Dynamic blood flow responses following single forearm muscle contractions at 
10, 20 and 40% MVC are shown in Figures 2A-C.  At all exercise intensities, both young 
and older groups demonstrated the typical temporal hyperaemic pattern, with peak 
hyperaemia occurring ~3-4 cardiac cycles post-contraction.  Consistent with previous 
findings from our laboratory (Carlson et al., 2008), older adults had a blunted immediate 
(first beat post-contraction; ~35-50%) and peak hyperaemic response (~45%) compared 
to young adults at all exercise intensities (Figures 2A-C; P <0.05).  This impairment was 
observed for a total of 4, 11, and 13 beats post-contraction for contraction intensities of 
10, 20, and 40% MVC, respectively.  This rapid hyperaemic response was unaffected by 
infusion of ascorbic acid in young adults.  In contrast to our hypothesis, ascorbic acid 
administration in older adults also did not augment the rapid hyperaemia seen following a 
brief single muscle contraction at any exercise intensity (Figures 2A-C).  Data were 






Effect of Ascorbic Acid on Forearm Haemodynamics during Rhythmic Handgrip 
Exercise 
Rhythmic dynamic handgrip exercise performed at 10% MVC significantly 
increased FBF and FVC from baseline within the first minute and throughout the duration 
of the exercise trial in both young and older adults (P < 0.05; Table 2, Figure 3).  
Absolute FBF and FVC tended to be lower in older compared with young adults when 
expressed as absolute blood flow (Table 2, Figure 3A; P = 0.06 – 0.09 for minutes 1-6), 
and was significantly lower when expressed as the percent increase in FBF and FVC 
from baseline (Table 2, Figure 3B; P < 0.05 for minutes 1-10).  Ascorbic acid infusion 
had no effect on FBF or FVC in young adults throughout the entire exercise bout (Table 
2, Figures 3A-B; P > 0.05), but significantly and progressively increased FBF and FVC 
from steady-state in older adults beginning at minute 7 (2nd minute of ascorbic acid 
infusion) until the end of exercise (minute 15) (Table 2, Figures 2A-B; P < 0.05).   
The peak effect of ascorbic acid infusion on FBF and FVC during steady-state 
exercise was calculated as the percent increase from minute 5 of exercise (end saline) to 
the final minute of exercise (end ascorbic acid; Figure 4A-B).  Ascorbic acid infusion 
increased FBF (34±7%) and FVC (32±7%) from steady-state exercise in older adults 
(both P < 0.05), whereas forearm haemodynamics were unchanged in young adults 
(∆FBF = 3±2%; ∆FVC = 1±2%; NS).  MAP and HR were not significantly different 
between young and older adults at baseline and were not significantly altered throughout 
the experimental trial (Table 2).  Brachial artery diameter at rest was not different in 
young and older adults (0.43±0.02 vs 0.42±0.02 cm; P = 0.55) and was similar after 5 
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minutes exercise with saline (0.42±0.02 vs 0.41± 0.02 cm) and at the end of ascorbic acid 
infusion (0.42±0.02 vs 0.41±0.02 cm). 
 
Effect of Prior Ascorbic Acid on Forearm Haemodynamics from Rest to Steady-State 
Exercise  
Ascorbic acid had no impact on resting forearm blood flow in either young or 
older adults (Figure 5A and B).  In contrast to the observed trend for an age-associated 
impairment in the absolute hyperaemic and vasodilatory responses seen during the 
transition from rest to steady-state exercise in trial 1, FBF in older adults during ascorbic 
acid infusion increased to similar values as young adults within the 1st minute of exercise 
(Figure 5A).  This pattern was similar throughout all 5 minutes of exercise (Figure 5A), 
and the FBF values at rest and after 5 minutes of steady-state exercise before and during 
concurrent ascorbic acid administration are shown in Figure 5b.  Percentage increases in 
FBF also were not significantly different at minute 1 of exercise in young and older 
adults (316 ± 40% vs 255±30%; P = 0.23), and were similar at end exercise (329±45% vs 
308±40%; P = 0.73).  MAP and HR were again not significantly different between young 
and older adults, thus FVC values were similar to FBF (data not shown).   
 
Effect of Ascorbic Acid on Endothelium-Dependent and -Independent Vasodilatation 
 Under control conditions, the increase in FBF in response to acetylcholine was 
blunted in older (∆ FBF = 420 ± 67%) compared with young adults (∆ FBF = 706 ± 
100%; P < 0.05), and this impairment was no longer observed during ascorbic acid 
administration (older ∆ FBF = 744 ± 83%; young = 709 ± 44%; NS; Figure 6A).  The 
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increase in FBF to sodium nitroprusside was also attenuated in older compared with 
young adults under control conditions (∆ FBF = 385 ± 43% vs 671 ± 113%, respectively; 
P < 0.05); however these responses were unaffected by ascorbic acid infusion (older 
∆FBF = 365 ± 32%; young = 662 ± 93%; Figure 6B).  No significant differences in HR 
or MAP were observed between or within groups (P > 0.05), thus changes in FVC were 
similar as FBF (not shown).   
 
Plasma Markers of Oxidative Stress 
 At baseline, plasma oxidized-LDL was greater in the older compared with young 
subjects (36.5±1.7 vs 28.8±2.4 U L-1; P < 0.05).  Infusion of ascorbic acid did not affect 
these plasma levels in either young (29.8.7±2.2 U L-1) or older adults (37.5±2.7 U L-1), 
which most likely reflects that the ascorbic acid was administered locally via brachial 
artery catheter and was dose-adjusted to forearm volume.  Importantly, the improvements 
in acetylcholine-mediated vasodilatation (see above) in older subjects is consistent with 
prior studies and provides evidence that ascorbic acid was effective at the level of the 
forearm vasculature (Taddei et al., 2000; Taddei et al., 2001).  
  
 Discussion 
In the present study, we directly determined whether acutely improving 
endothelial vasodilator function would augment blood flow responses to contracting 
muscle in ageing humans.  The primary new findings of the present study are as follows.  
First, acute infusion of ascorbic acid does not impact the rapid hyperaemic responses to 
single, brief mild-to-moderate muscle contractions in young or older adults.  Second, 
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local ascorbic acid infusion during rhythmic handgrip exercise increased forearm blood 
flow by ~30% in older adults during continuous exercise, and this was due to significant 
increases in forearm vascular conductance (vasodilatation).  In contrast, ascorbic acid did 
not influence forearm haemodynamics in the young subjects.  Third, when older adults 
transitioned from rest to steady-state exercise with concurrent ascorbic acid infusion, 
steady-state blood flow was significantly improved and the impaired responses under 
control conditions were no longer observed compared with young adults.  Finally, age-
related impairments in the vasodilator responses to the endothelium-dependent agonist 
acetylcholine were no longer evident during ascorbic acid infusion.  To the best of our 
knowledge, these data are the first to demonstrate that acute improvements in 
endothelium-dependent vasodilatation are associated with augmented blood flow 
responses to dynamically contracting skeletal muscles of ageing humans. 
 
Ageing and Contraction-Induced Rapid Vasodilatation: effect of ascorbic acid 
 In young healthy adults, single (brief) muscle contractions evoke a rapid 
hyperaemic response that is graded with contraction intensity (Corcondilas et al., 1964; 
Tschakovsky et al., 2004; Kirby et al., 2007).  Although the exact mechanisms 
underlying this phenomenon are unclear, the impact of a “muscle pump” effect appears 
negligible and thus vascular smooth muscle cell hyperpolarization and subsequent 
vasodilatation is obligatory to observe this response (Hamann et al., 2004).  Recent 
studies implicate a role for several potential contributors to this rapid vasodilatation 
including mechanical effects on the vasculature (which is in part dependent on an intact 
endothelium) (Clifford et al., 2006; Kirby et al., 2007), K+ released during muscle 
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activation (Armstrong et al., 2007), and acetylcholine spillover from motor nerves 
(VanTeeffelen & Segal, 2006).  Further, data from Duza & Sarelius (2004) obtained from 
skeletal muscle arterioles of mice indicate that an intact endothelium is obligatory for the 
initiation of contraction-induced vasodilatation.  In agreement with recent findings from 
our laboratory (Carlson et al., 2008), the data from the present study indicate that the 
rapid hyperaemic responses to single, brief muscle contractions of mild-to-moderate 
intensities are significantly impaired in older compared with young healthy adults.  
Further, our data indicate that improving acetylcholine-mediated (endothelium-
dependent) vasodilatation via ascorbic acid infusion does not impact on the rapid 
hyperaemic responses in young, and more importantly, older humans.  Together, these 
observations might provide further support for the hypothesis that the “normal” rapid 
vasodilator responses are not mediated via acetylcholine in humans (Brock et al., 1998; 
Dyke et al., 1998; Naik et al., 1999).  Although we cannot completely rule out a possible 
role of impaired endothelial function in this blunted rapid vasodilatory response with age, 
our data indicate that this is insensitive to the improvements in vascular function 
mediated via ascorbic acid.  We speculate that this age-related impairment may be due to 
impaired K+ signaling (either release of or responsiveness to) or impaired mechanically-







Ageing and Exercise Hyperaemia During Rhythmic Handgrip Exercise: effect of 
ascorbic acid 
 In the present study, we infused ascorbic acid into the brachial artery during 
rhythmic handgrip exercise to determine whether muscle blood flow would increase 
during sustained (continuous) exercise in young and older healthy adults.  Our findings 
clearly indicate that blood flow increased ~30% in older adults, whereas ascorbic acid 
was without effect in young adults (Figure 2).  Further, when the subjects transitioned 
from rest to exercise with concurrent ascorbic acid infusion (Figure 5), similar results 
were obtained, indicating that this effect of ascorbic acid on muscle blood flow in older 
subjects cannot be attributed to a drift in haemodynamics over the course of the original 
fifteen minute exercise bout.  Given that there were no changes in heart rate or mean 
arterial pressure throughout the exercise trials, the increases in muscle blood flow were 
due to a corresponding increase in vascular conductance (i.e. vasodilatation).  Further, we 
demonstrated that the age-related decrease in endothelium-dependent vasodilatation (via 
acetylcholine) is abolished after infusion of ascorbic acid.  Taken together, these data are 
the first to demonstrate that acute improvements in endothelial function increases muscle 
blood flow during continuous exercise via local vasodilatation in older healthy humans.    
 Endothelial dysfunction is one hallmark of vascular ageing, and represents a 
significant risk for cardiovascular disease risk and progression (Luscher et al., 1993b; 
Shimokawa, 1999).  In addition to its role in maintaining vascular health, the endothelium 
produces vasodilator (e.g., nitric oxide, prostacyclin, endothelium-derived 
hyperpolarizing factor) and vasoconstrictor (e.g., endothelin-1, thromboxane) substances 
that significantly influence vascular tone (Luscher et al., 1993a).  Indeed, recent evidence 
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implicates a significant role for endothelium-derived substances in controlling muscle 
blood flow and vascular tone in contracting muscle of young humans (Hillig et al., 2003; 
Clifford & Hellsten, 2004; Saltin, 2007).  As such, there has been much speculation that 
age-related reductions in endothelium-dependent vasodilatation play a role in the 
impaired skeletal muscle perfusion often observed during exercise in older healthy and 
diseased adults (Drexler & Hornig, 1996; Proctor & Parker, 2006).  Consistent with this, 
work by Schrage and colleagues indicate that the normal contributions of nitric oxide and 
vasodilating prostaglandins to exercise hyperaemia are impaired with age (Schrage et al., 
2007).  In the present study, we extend these observations by demonstrating that acute 
improvements of endothelial vasodilator function (achieved via ascorbic acid 
administration) is associated with significant improvements in muscle blood flow during 
exercise in older but not young adults.  These collective observations provide support for 
the hypothesis that endothelial dysfunction is mechanistically-linked with altered 
vascular control during dynamic forearm exercise in ageing humans. 
 
Potential Mechanisms 
Although we clearly demonstrate that ascorbic acid significantly improves muscle 
blood flow to contracting muscle during continuous exercise via vasodilatation in older 
adults, the signaling mechanism(s) underlying this improvement remains unclear.  
Consistent with previous data (Taddei et al. 2000, Taddei et al. 2001), ascorbic acid did 
not influence resting forearm haemodynamics, indicating that the improvements in blood 
flow during exercise (and acetylcholine infusion) in older adults is only observed during 
stimulation of the endothelium.  It is possible that ascorbic acid is acting to increase nitric 
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oxide bioavailability, an event that could be due to direct scavenging of free radicals  
(e.g, O2-)  (Nishikimi, 1975), or via the stabilization for nitric oxide synthesis 
tetrahydrobiopterin (BH4), an important cofactor for nitric oxide synthesis (Heller et al., 
2001).  In this context, recent work in older experimental animals and humans support the 
hypothesis that increasing BH4 concentrations significantly improve endothelium-
dependent vasodilatation (Eskurza et al., 2005; Delp et al., 2008).  Whether this translates 
to improved vascular control in contracting muscle of ageing humans is unknown.  
Another possibility is that age-associated oxidative stress increases endothelin-mediated 
vasoconstriction, and that ascorbic acid acutely reverses this detrimental effect of 
endothelin on local vasodilator function, thereby allowing for greater hyperaemic 
responses during exercise in older adults  (Bohm et al., 2007; Van Guilder et al., 2007).  
Clearly, future studies will be needed to determine the specific mechanisms involved in 
the ascorbic acid-mediated improvement in muscle blood flow and vascular control 
during exercise of ageing humans. 
If the ascorbic acid in the present study is working specifically to reduce the 
accumulation of reactive oxygen species during exercise and this in turn improves 
vascular control in older adults, we do not know whether these species are being 
generated within the blood vessels or from the contracting skeletal muscle.  Our finding 
that acetylcholine-mediated vasodilatation was restored in older adults during ascorbic 
acid does provide indirect evidence that at least part of this stress is present at rest and 
most likely within the endothelial cells  (Donato et al., 2007).  However, it is well known 
that muscle contractions can increase reactive oxygen species production (Bailey et al., 
2007), and this coupled with evidence of reduced antioxidant defense systems in skeletal 
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muscle of ageing humans (Pansarasa et al., 1999), clearly suggests a possible interaction 
between ascorbic acid and free radicals generated from the muscle tissue.  Again, future 
investigations will be required to determine the potential sources of free radical 
generation during muscle contractions in ageing humans. 
 
Experimental Considerations 
 Several experimental considerations exist for the present study.  First, it is 
possible that the absolute forearm blood flow and vascular conductance values during 
steady-state exercise in Trial 1 (prior to ascorbic acid) tended to be lower in older adults 
due to the trend for an age-related decline in MVC (and thus exercise workload) 
compared with young subjects.  Although this was not statistically significant (~18%; P = 
0.1), this could partially explain why steady-state haemodynamics were lower in our 
older subjects, especially when viewed in light of a recent study showing no difference in 
forearm blood flow during handgrip exercise with age (Donato et al., 2006).  With 
respect to our single contraction data, we have previously demonstrated that the 
immediate hyperaemic response is independent of any age-related difference in workload 
(Carlson et al., 2008), so we don’t believe this influences the interpretation of our single 
contraction data.  Irrespective of the potential discrepancy in forearm haemodynamics 
during steady-state exercise between studies, we would like to emphasize that this should 
not influence the interpretation of our data as it relates to the ascorbic acid-mediated 
improvement in forearm blood flow and vascular conductance of ascorbic acid during 
rhythmic handgrip exercise.   
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Second, in regards to our pharmacological tests, we found that the vasodilator 
responses to the endothelial agonist acetylcholine were significantly impaired with age, 
an observation that is very consistent with previous studies on this topic (DeSouza et al., 
2000; Taddei et al., 2000; Taddei et al., 2001; DeSouza et al., 2002).  We also found that 
the responses to sodium nitroprusside (endothelium-independent vasodilator) were 
reduced with age, and these data are in contrast to some (DeSouza et al., 2000; Taddei et 
al., 2001), but not all (Taddei et al., 2000; Newcomer et al., 2005; Parker et al., 2006) 
previous studies showing that vascular smooth muscle cell responsiveness is preserved 
with age in humans.  The reasons for this discrepancy are unclear, but could suggest that 
preserved smooth muscle cell function is simply not a universal finding with healthy 
ageing.  However, it is important to note that in the present study, the age-associated 
differences in vasodilatation to acetylcholine were abolished during ascorbic acid 
infusion, whereas the responses to sodium nitroprusside were unaffected.  Thus, the 
ascorbic acid-mediated increases in forearm blood flow we observed during rhythmic 
exercise were associated specifically with improved endothelium-dependent vasodilator 
function, and were not related to changes in smooth muscle cell responsiveness.   
 Finally, we employed mild-to-moderate intensity exercise of a small muscle mass 
(forearm) to isolate the local effects of muscle contraction on vascular tone, and limit the 
potential modulatory influences of cardiac output (systemic arterial flow) and the 
sympathetic nervous system on muscle blood flow responses (Dinenno et al., 2005; Koch 
et al., 2005).  Further, the forearm vasculature is not under greater tonic sympathetic 
vasoconstriction at rest (Dinenno et al., 2002), whereas the leg circulation is 
characterized by augmented basal α-adrenergic vasoconstrictor tone (Dinenno et al., 
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2001).  Future studies will be required to determine whether ascorbic acid is capable of 
improving vascular control in ageing humans during higher intensity exercise or larger 
muscle mass exercise (e.g., cycling) where cardiac output and sympathetic neural 
influences are involved in the integrative control of skeletal muscle blood flow. 
   
Conclusions 
The collective findings from the present investigation indicate that acute 
improvements in endothelial vasodilator function are associated with augmented blood 
flow responses to contracting muscles of aging humans.  However, this improved 
hyperaemia was only observed during continuous dynamic exercise, as the responses to 
single, brief contractions were not influenced by ascorbic acid and thus still significantly 
impaired with age.  The exact signaling mechanisms underlying this improved exercise 
hyperaemia during continuous exercise need to be elucidated, and whether other longer-
term interventions that improve endothelial vasodilator function in humans (e.g. aerobic 
exercise training) translate to improved muscle blood flow during exercise in older adults 
remains to be determined.  Finally, the divergent effects of ascorbic acid on contraction-
induced rapid vasodilatation versus sustained exercise highlight the complex alterations 
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       Table 1: Subject Characteristics and Baseline Haemodynamics 
Variable Young Older 
Male:Female 9:5 9:5 
Age (years) 22 ± 1 65 ± 2* 
Body mass index (kg m-2) 24.5 ± 0.8 24.1 ± 0.8 
Body fat (%) 19.5 ± 2.62 29.04 ± 2.45* 
Whole-Body FFM (kg) 58.68 ± 3.76 48.59 ± 3.48 
Forearm FFM (g) 842 ± 75 700 ± 36 
Forearm volume (ml) 968 ± 75 830 ± 68 
MVC (kg) 44 ± 3 36 ± 3 
10% MVC (kg) 4.4 ± 0.3 3.6 ± 0.3 
Total cholesterol (mmol l-1) 4.0 ± 0.3 5.1 ± 0.4* 
LDL cholesterol (mmol l-1) 2.6 ± 0.2 3.4 ± 0.3* 
HDL cholesterol (mmol l-1) 1.1 ± 0.1 1.2 ± 0.1 
Triglycerides (mmol l-1) 0.7 ± 0.1 1.2 ± 0.3 
Mean arterial pressure (mmHg) 94 ± 3 99 ± 2 
Heart Rate (beats min-1) 55 ± 2 59 ± 2 
Forearm blood flow (ml min-1) 35 ± 6 34 ± 3 
Forearm blood flow (ml 100g-1 min-1) 3.4 ± 0.4 4.1 ± 0.3 
Forearm VC (ml min-1 100 mmHg -1) 36 ± 5 34 ± 3 
Data presented as mean ± SEM.  FFM = fat free mass; MVC = maximal voluntary 
contraction; LDL = low density lipoprotein; HDL = high density lipoprotein; MAP = 
mean arterial pressure; HR = heart rate; VC = vascular conductance.  *P < 0.05 versus 










Data are mean ± SEM. HR = heart rate; MAP = mean arterial pressure; FVC = forearm vascular conductance; * P < 0.05 vs young;  
† P <0.05 vs end control saline (minute 5 of exercise) 
 
Time (min) Age Rest 1 2 3 4 5 6 7 8 9 10 11 12 13 14 15 
HR (beats min-1) 
Young 55±2 59±2 57±2 57±2 58±2 58±2 58±2 58±2 58±2 58±2 57±2 57±2 58±2 58±3 58±2 58±2 
Older 59±2 63±2 63±2 62±2 63±2 62±2 62±2 62±2 63±2 62±2 62±2 62±2 62±2 62±2 63±2 62±2 
MAP (mmHg) 
Young 94±3 98±3 99±3 99±3 98±3 97±3 98±3 98±3 98±3 98±3 96±3 98±3 98±3 98±3 97±3 98±3 
Older 99±2 103±2 103±2 104±2 104±2 103±2 103±2 104±2 104±2 104±2 103±2 104±2 105±2 103±3 102±2 103±2 
FVC 
(ml min-1 mmHg-1) 
Young 36±5 132±14 135±13 135±12 136±13 141±13 141±13 140±13 141±13 146±14 145±15 145±14 144±14 142±14 145±15 144±14 
Older 34±3 94±13* 100±13* 100±14* 99±14* 100±15* 104±14* 110±15 113±15 112±14 117±16 124±18 122±19 126±21 128±21 132±21 
Δ FVC (%) 
Young - 335±48 346±47 355±52 358±53 378±58 380±61 372±57 368±52 383±52 377±54 383±58 379±59 374±59 378±55 375±54 
















































Figure 1: Experimental Timeline.  Following placement of the brachial artery catheter and general setup, subjects 
received a 5 minute intra-arterial infusion of either acetylcholine or sodium nitroprusside to assess endothelium-
dependent or endothelium-independent vasodilatation, respectively.  Next, single 1-s dynamic forearm muscle 
contractions were performed at 10, 20, and 40% MVC in triplicate and in random order.  Noted as Trial 1, rhythmic 
handgrip exercise was performed at 10% MVC for 5 minutes with saline to achieve “steady-state” haemodynamics, 
and the next 10 minutes consisted of continued exercise with concurrent ascorbic acid infusion equaling a total of 15 
minutes. The dose of ascorbic acid was then reduced to 40% of the original dose and infused for the remainder of the 
experiment.  During maintenance ascorbic acid administration, endothelium-dependent and -independent 
vasodilatation was again tested, followed by single contractions, and then a second 5-minute rhythmic handgrip 
































































* * * * * * * * * * 
Figure 2:  Dynamic rapid hyperaemic responses to single forearm muscle contractions 
at 10, 20, and 40% MVC.  The peak hyperaemic response occurred at 3-4 cardiac cycles 
post-contraction for all exercise intensities regardless of age or ascorbic acid administration.  
There were significant age group differences in contraction-induced rapid vasodilatation for 
all intensities, and ascorbic acid did not impact this response in either young or older adults. 






















































Figure 3:  Forearm hyperaemic responses to mild rhythmic handgrip exercise before 
and during ascorbic acid infusion.  Prior to ascorbic acid, absolute forearm blood flow 
tended to be lower in older vs young adults during mild intensity steady-state exercise (A; * P 
= 0.06 – 0.09 for minutes 1-6).  When expressed as percentage increases from baseline, 
forearm hyperaemic responses were significantly reduced in older adults (B; * P < 0.05 for 
minutes 1-10).  Infusion of ascorbic acid significantly increased forearm blood flow in older, 
but not young adults during continued exercise. † P <0.05 vs steady state exercise within 




















































Figure 4:  Peak effect of ascorbic acid on forearm blood flow and vascular 
conductance during steady-state exercise.  Acute infusion of ascorbic acid increased 
forearm blood flow by ~30% in older adults, whereas the increase was minimal and 
non-significant in young adults (A). Similar responses were observed when quantified 
as changes in vascular conductance, indicating that the increase in blood flow was due 



















































Figure 5:  Effect of ascorbic acid on forearm blood flow from rest to steady-state 
handgrip exercise.  When ascorbic acid was administered prior to the onset of exercise, 
forearm blood flow increased to similar levels within 1 minute of exercise in young and 
older adults and this persisted throughout the exercise trial (A). In Panel B, forearm blood 
flow at rest and after 5 minutes of steady-state exercise from Trial 1 (no ascorbic acid; 
control) and Trial 2 (concurrent ascorbic acid infusion) are shown.† P < 0.05 vs without 
ascorbic acid within age group. 
 

















































Figure 6:  Forearm vasodilatation to intra-arterial infusion of acetylcholine and 
sodium nitroprusside in young and older adults.  At baseline, percentage increases in 
forearm blood flow to acetylcholine (endothelium-dependent) were significantly impaired 
in older compared with young adults, and this age-associated impairment was abolished 
during ascorbic acid infusion (A).  Older adults also had an impaired forearm blood flow 
response to sodium nitroprusside (endothelium-independent) at baseline, and this was 
unaffected during ascorbic acid infusion (B).  * P <0.05 vs young; † P <0.05 vs without 










Consent to Participate in a Research Study 
Colorado State University 
 
TITLE OF STUDY:  Aging, Endothelial Dysfunction, and Impaired Vascular Control During    
                                     Exercise 
PRINCIPAL INVESTIGATOR:  Frank A. Dinenno, Ph.D.  491-3203 
CO-PRINCIPAL INVESTIGATOR:  Wyatt Voyles, M.D.  663-3107                                                                
 
WHY AM I BEING INVITED TO TAKE PART IN THIS RESEARCH?  You are a man or 
woman between the ages of 18-35 or 55-90 years.  You are either not regularly exercising or are 
moderately active.  Our research is looking at the effect of aging on muscle blood flow control 
during exercise. 
 
WHO IS DOING THE STUDY?  This research is being performed by Frank Dinenno, Ph.D., 
of the Department of Health and Exercise Science, and Wyatt Voyles, M.D., of the Heart Center 
of the Rockies.  Trained graduate students, undergraduate students, research assistants, or 
research associates are assisting with the research.  These studies are paid for by the National 
Institute on Aging (a part of the US Government). 
   
WHAT IS THE PURPOSE OF THIS STUDY?  The way in which blood flow (and oxygen 
delivery) and vascular function are regulated by local factors during exercise is being studied.  
Importantly, cardiovascular regulation under these conditions might change in older people and 
might be different between men and women.  The purpose of the research is to understand how 
age-related changes in blood vessel function might affect blood flow to muscle during exercise.    
 
WHERE IS THE STUDY GOING TO TAKE PLACE AND HOW LONG WILL IT LAST?  
This whole research project will take place over a period of approximately two years.  However, 
your part of this study will be either:  
 ______   1) one or two visits over a several day period, or                      ________  (your initials) 
 ______   2) several visits over a few to several weeks.                             ________  (your initials) 
 
WHAT WILL I BE ASKED TO DO?  This consent form applies to a large research project.  
You are only being asked to participate in one part of the total project.  Depending on the part of 
the research project that you are involved in, you will be asked to participate in some of the 
following procedures.  Many potential procedures are described in the section below.  However, 
the procedures that you will be asked to do for this part of the study have a check mark next to 
them.  The check marks were put there by one of the researchers.  The time associated with each 
procedure reflects the amount of time you will spend performing or undergoing the procedure, 
not the total time of the study.  A member of the research team will fully explain each checked 
procedure that applies to your participation and specifically how long each session (total time) in 
the laboratory will be.        
 
_____ Health and Physical Activity Questionnaire.  You will be asked to answer some questions 
about your health and exercise habits to determine if you can participate in the study. (~20 
minutes)                            
            ________ (your initials) 
 
_____ Pregnancy Test.  If you are female you will be required to have a sample of your urine 
tested for the presence of human chorionic gonadotropin (HCG), a hormone which indicates 
whether you may be pregnant.  This will require approximately 1 cup of your urine. If you are 
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pregnant or the test indicates that you are pregnant you will not be able to participate in this 
study. (~10 minutes) 
                    ________ (your initials) 
 
_____ Heart Rate and Blood Pressure.  Heart rate will be measured by placing three sticky 
electrodes on your chest and reading the electrocardiogram (ECG) signal.  Blood pressure will 
be measured with an automated machine that requires the placement of a cuff around your upper 
arm (bicep), or a small cuff on your finger. (continuous monitoring throughout study) 
                  _______ (your initials) 
 
_____ Graded Exercise Test.  If you are in the 55-90 yr-old age group, you will be asked to 
perform a maximal exercise test on a treadmill under the supervision of a physician.  This test 
will occur in the Human Performance Clinical/Research Laboratory in the Department of Health 
and Exercise Science on the CSU campus.  Sticky electrodes will be placed on your chest, and 
you will walk briskly or jog while the steepness of the treadmill is increased.  Your blood 
pressure and heart beat will be closely measured during and immediately after the test. (~1 hour)            
                 ________  (your initials) 
    
____ Body Composition.  The fat, muscle, and bone in your body will be measured using an x-
ray device (dual-energy x-ray absorptiometer) that will scan you from head to toe while you lie 
quietly on a special table for approximately 20 minutes.  The amount of x-ray radiation you will 
receive is extremely low. (~20 minutes) 
                                                     ________  (your initials) 
 
_____ Forearm Volume.  The volume of your forearm will be measured via water displacement.   
You will place your forearm in a large water-filled cylinder, and the spillover of this water is 
collected in a large graduated cyclinder to determine the volume.  (~5 minutes)   
                          ________  (your initials) 
 
_____ Forearm Exercise.  You will lay flat on a bed and squeeze your hand and forearm muscles 
using a handgrip device while your hand and arm are comfortably secured. The intensity of the 
exercise will range from very easy to moderately difficult, and you will be asked to perform this 
exercise for ~20 minutes a couple of times throughout the study with plenty of rest in between 
exercise trials. (1 – 2 hours) 
                                                                                                                    ________  (your initials) 
  
_____ Maximum Voluntary Contraction. This will consist of 3-4 trials where you will squeeze 
your muscles (either forearm, calf, or thigh) and generate as much force as you can.  You will be 
asked to generate as much force over the course of ~3 seconds and hold this force another 5 
seconds.  After a 2-3 minute rest period, you will be asked to do this again.  This is typically used 
to determine how heavy of exercise you perform so everybody is exercising at similar percentages 
of their maximum. (~ 20 minutes) 
                                                                                                                    ________  (your initials) 
  
____  Doppler Ultrasound.  The blood flow in your arm will be measured using an ultrasound 
machine which produces sound waves to measure your blood vessel size and the speed of your 
blood.  (2-3 hours)  




____  Reactive Hyperemia.  A blood pressure cuff will be placed on your upper arm and inflated 
really tight to temporarily block the blood to your forearm.  After 5 or 10 minutes, the cuff will be 
released and the blood flow in your forearm will be measured.  This test is a measure of how 
much your blood vessels can relax and will be repeated several times throughout the study. (1- 
1.5 hours) 
                   ________  (your initials)  
 
____  Flow-Mediated Vasodilation.  A blood pressure cuff will be placed on your forearm and 
inflated really tight to temporarily block the blood to your hand.  After 5 or 10 minutes, the cuff 
will be released and the diameter changes of the blood vessels in your arm will be measured 
using Doppler ultrasound.  This will be repeated several times throughout the study. (1-1.5 
hours)    
                    ________ (your initials) 
 
____ Blood Sample.  Up to 100 ml (approximately 7 tablespoons) of your blood will be drawn 
from a vein on the front of your elbow or artery in a standard fashion using a sterilized 
hypodermic needle. (~15 minutes)   
                                                                 ________ (your initials) 
 
** For Arterial Catherization:  If you are allergic to lidocaine or novacaine, or have had a 
negative reaction to medicines injected while at the dentist, you should notify us immediately and 
not have any of these procedures done.   
 
____ Venous Catheterization.  Your skin will be cleaned and a catheter (plastic needle) will then 
be inserted on the front side of your elbow and secured to the skin.  In some cases, a local 
anesthetic might be used to reduce any discomfort. (~2-4 hours) 
                                                                 ________ (your initials) 
 
____ Brachial Artery Catheterization.  Your skin will be cleaned and a local anesthetic will be 
given with a small needle to numb the area where the catheter will be placed (front side of your 
elbow).  The catheter (plastic needle) will then be inserted and secured to the skin. (~2-4 hours)   
               ________  (your initials) 
 
____  Drug Administration (~ 2 - 4 hours): 
 




Vasodilators – temporarily relax the blood vessels (minutes) 
___ Acetylcholine 
___ Sodium Nitroprusside 
 
No major effects 
___ Ascorbic Acid (Vitamin C) 
                    ________  (your initials) 
 
FUTURE USE OF BLOOD SAMPLES 
It is possible that we may want to use any extra blood for future research not described in this 
consent form.  For example, this may include determination of certain gene expressions that 
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relate to various measures of cardiovascular function measured as part of this study.  This 
information will remain private as will all of the data collected from the study.   
Only choose one of the following:       
_____ I give permission for the use of my blood or muscle tissue collected as part of the current 
study only.                     
           ________  (your initials) 
_____ I give permission for the use of my blood or muscle tissue for the current study as well as 
for future studies.                                  
           ________  (your initials) 
 
ARE THERE REASONS WHY I SHOULD NOT TAKE PART IN THIS STUDY? 
If you are not 18-35 or 55-90 years of age, are pregnant, are a regular smoker, or have any 
diseases that would affect our measurements or significantly increase the risks associated with 
this study, we will not be able to include you in the research.  
 
WHAT ARE THE POSSIBLE RISKS AND DISCOMFORTS?  
(The procedures that apply to your proposed participation are checked)  
 
 _____  Health and Physical Activity Questionnaire – there are no known risks associated with 
answering health questions.  All information is kept strictly confidential.                  
                     ________  (your initials) 
 _____  Graded Exercise Test – there is a risk of fatigue (temporary muscle tiredness), muscle 
strain, heart beat abnormalities (arrhythmias), a 0.01% chance of death (e.g., heart attack in 
people who have heart problems), a 0.02% risk of cardiac arrhythmias that would require you 
to go to a hospital (in people who have heart problems), and a risk of an increase or decrease 
in blood pressure.   
                                                                                                                 ________  (your initials) 
 
 _____ Body composition (DEXA) scan – the risks associated with the DEXA are very low.  
The radiation you will receive is less than 1/3000th of the Food and Drug Administration 
(FDA) limit for annual exposure.  The FDA is a government organization responsible for 
medical safety.   In other words, you could receive 3000 DEXA scans in a single year and still 
not meet the FDA limit for radiation exposure.  In this study you will receive one scan.  The 
more radiation you receive over the course of your life, the greater the risk of having 
cancerous tumors or of inducing changes in genes.  The radiation in this study is not expected 
to greatly increase these risks, but the exact increase in such risks is not known.  Women who 
are pregnant or could be pregnant should receive no unnecessary radiation and should not 
participate in this study.                                                                                     





 _____ Muscle contractions – There is a slight risk of muscle strain and muscle soreness 
resulting from brief strong muscle contractions.  Soreness should not last more than two days 
or affect your normal function.                                                              
                     ________  (your initials) 
 
 _____ Reactive Hyperemia/Flow-Mediated Vasodilation- There is a risk of temporary 
discomfort of the upper arm when the blood pressure cuffs are inflated.  The discomfort might 
be greater the longer the cuffs are inflated. 
                          _______  (your initials)  
 
 _____ Blood sample – The risks associated with blood drawing include bruising, slight risk of 
infection, soreness, and fainting.  These are minor risks which usually do not last more than 
one day if they occur.                                                                                
                     ________  (your initials) 
 
 _____ Venous Catheterization- The risk of allergic reaction to lidocaine is extremely low. 
There is a risk of bruising, clotting, slight risk of infection, local soreness, and fainting.              
                    ________  (your initials) 
 
 _____ Arterial Catheterization – The risk of allergic reaction to lidocaine is extremely low.  
There is a risk that pain or discomfort may be experienced when the catheter is inserted in the 
artery, and local soreness after the study.  In about 1 in 10 cases a small amount of bleeding 
under the skin will cause a bruise.  There is about a 1 in 1,000 risk of infection or significant 
blood loss.  In about 1 in 4,000 damage may occur to the artery requiring surgery in order to 
prevent loss of limb and/or digit (finger) function. 
                    ________  (your initials) 
 
 _____ Drug Administration - The risks associated with drug administration include temporary 
increases or decreases in blood pressure and heart rate.  Any changes in blood pressure and 
heart rate during this part of the study are modest and less severe than experienced during the 
treadmill test.  These symptoms should resolve when the drug stops.  With any of the 
vasoconstrictor drugs, there is a slight risk that ischemia (lack of blood to the tissues) could 
occur (e.g. heart attack).  Risks of these effects are minimized by calculating the amount of 
drug given relative to the size of your forearm, and not the entire body.  Finally, there is a 
potential risk of an allergic reaction to vasoactive drug administration.  If you are allergic to 
aspirin, you should not participate.  
                    ________  (your initials) 
    
 It is not possible to identify all potential risks in research procedures, but the researcher(s) 
have taken reasonable safeguards to minimize any known and potential, but unknown, risks. 
 
WILL I BENEFIT FROM TAKING PART IN THIS STUDY?  There are no direct benefits 
to you for participating in this study beyond receiving information on your body composition and 




DO I HAVE TO TAKE PART IN THE STUDY?   Your participation in this research is 
voluntary.  If you decide to participate in the study, you may withdraw your consent and stop 
participating at any time without penalty or loss of benefits to which you are otherwise entitled.   
 
 WHAT WILL IT COST ME TO PARTICIPATE?  There is no cost to you for participating 
except that associated with your transportation to our facilities. 
 
WHO WILL SEE THE INFORMATION THAT I GIVE?  We will keep private all research 
records that identify you, to the extent allowed by law. Your information will be combined with 
information from other people taking part in the study. When we write about the study to share it 
with other researchers, we will write about the combined information we have gathered. You will 
not be identified in these written materials. We may publish the results of this study; however, we 
will keep you name and other identifying information private.  
 
We will make every effort to prevent anyone who is not on the research team from knowing that 
you gave us information, or what that information is.  For example, your name will be kept 
separate from your research records and these two things will be stored in different places under 
lock and key. You should know, however, that there are some circumstances in which we may 
have to show your information to other people.  For example, the law may require us to show 
your information to a court or to the Human Research Committee at CSU.   
 
CAN MY TAKING PART IN THE STUDY END EARLY?  Your participation in the study 
could end in the rare event of muscle strain, if you become pregnant, or if you miss an excessive 
number of appointments.   
 
WILL I RECEIVE ANY COMPENSATION FOR TAKING PART IN THIS STUDY?   For 
experiments that involve the blood sample, venous or arterial catheterization, you will be paid 
$25/hour.  
 
WHAT HAPPENS IF I AM INJURED BECAUSE OF THE RESEARCH?  Please be 
aware that for this study the University has made special arrangements to provide initial 
medical coverage for any injuries that are directly related to your participation in this research 
project. The research project will provide for the coverage of reasonable expenses for 




Because Colorado State University is a publicly-funded, state institution, it may have only limited 
legal responsibility for injuries incurred as a result of participation in this study under a 
Colorado law known as the Colorado Governmental Immunity Act (Colorado Revised Statutes, 
Section 24-10-101, et seq.).  In addition, under Colorado law, you must file any claims against 
the University within 180 days after the date of the injury.  
 
In light of these laws, you are encouraged to evaluate your own health and disability insurance to 
determine whether you are covered for any physical injuries or emotional distresses you might 
sustain by participating in this research, since it may be necessary for you to rely on your 
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individual coverage for any such injuries. Some health care coverages will not cover research-
related expenses. If you sustain injuries, which you believe were caused by Colorado State 
University or its employees, we advise you to consult an attorney. 
 
Questions concerning treatment of subjects' rights may be directed to Celia S. Walker at (970) 
491-1563.  
 
WHAT IF I HAVE QUESTIONS?  Before you decide whether to accept this invitation to take 
part in the study, please ask any questions that might come to mind now.  Later, if you have 
questions about the study, you can contact the principal investigator, Frank Dinenno, Ph.D., at 
(970)491-3203, or via email at fdinenno@cahs.colostate.edu.  If you would like to ask a medical 
doctor about your participation in the study, you may contact Wyatt Voyles, M.D. at 663-3107.   
If you have any questions about your rights as a volunteer in this research, contact Celia Walker, 
Director of Regulatory Compliance, at 970-491-1553.  We will give you a copy of this consent 
form to take with you. 
 
Your signature acknowledges that you have read the information stated and willingly sign this 
consent form.  Your signature also acknowledges that you have received, on the date signed, a 
copy of this document containing 9 pages. 
 
  
_________________________________________      _____________________ 
Signature of person agreeing to take part in the study      Date 
 
_________________________________________ 
Printed name of person agreeing to take part in the study 
 
 
_______________________________________     _____________________ 
Name of person providing information to participant       Date 
 
_________________________________________    
Signature of Research Staff   
 
** List of Contact Numbers in Case of Medical Emergency 
    Wyatt Voyles, M.D.      Work: 970-221-1000 (24 hours a day) 
    Poudre Valley Hospital Emergency    970-297-6250 
    Frank A. Dinenno, Ph.D.    Work: 970-491-3203 
        Home: 970-266-1719 
